CEO Robert Adams follows in his father’s footsteps.
Medicare tops to-do list for lawmakers
Jan 14, 2008
Legislators are planning to resume discussions about Medicare after passing slimmed-down legislation on this program before the winter recess.
Researchers find holes in antipsychotics’ off-label uses
Jan 09, 2008
Antipsychotic drugs that are used “off-label” for controlling violent behavior in mentally challenged patients are less effective than placebos and dummy pills, according to a new British study.
Execs: Private equity views resident care as a priority
By
Liza Berger
Dec 01, 2007
Skilled nursing leaders defended their care practices in the wake of a New York Times story blasting private equity firms that have recently bought facilities.
CMS to recover $4 billion in overpayments for Part D drugs
By
Haymarket Media
Oct 15, 2007
The Centers for Medicare & Medicaid Services said that because actual drug costs were lower than expected, Part D drug plan sponsors will need to return $4 billion to the agency.
Housing market fear doesn’t affect long-term care confidence
By
Liza Berger
Oct 01, 2007
While the rest of the housing market is gripped by credit fears, those in long-term care are staying confident.
CMS: Part D drug premiums to increase
By
Haymarket Media
Oct 01, 2007
The average monthly premium for Medicare Part D prescription drug coverage will increase slightly over the previous two years, the Centers for Medicare & Medicaid Services said last week.
Study: Low-calorie diets fight aging process
By
Haymarket Media
Sep 24, 2007
The key to living longer may involve calorie deprivation, a new study suggests. But humans might able to find the same effects in a pill form.
Popular Alzheimer’s drug going generic
By
Haymarket Media
Sep 04, 2007
The U.S. Food and Drug Administration has provided tentative approval to Ranbaxy Pharmaceuticals Inc. to make and market the generic version of dementia treatment Razadyne.
Researchers: Key to living long is in genes
By
Haymarket Media
Aug 30, 2007
Living to 100 may hinge on having special genes that balance out the harmful effects of other, “bad” genes, researchers say. Their discovery could lead to the development of medications aimed...